MAIA Biotechnology, Inc. (MAIA)
(Delayed Data from AMEX)
$1.52 USD
-0.06 (-3.80%)
Updated Aug 6, 2025 03:59 PM ET
After-Market: $1.52 0.00 (0.00%) 7:32 PM ET
3-Hold of 5 3
D Value A Growth B Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, MAIA Biotechnology, Inc. has a market cap of $47.89M, which represents its share price of $1.58 multiplied by its outstanding shares number of 30.31M. As a small-cap company, MAIA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MAIA 1.52 -0.06(-3.80%)
Will MAIA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MAIA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MAIA
Best Momentum Stocks to Buy for May 6th
New Strong Buy Stocks for May 6th
MAIA: What are Zacks experts saying now?
Zacks Private Portfolio Services
MAIA Biotechnology, Inc. (MAIA) Upgraded to Buy: Here's What You Should Know
Other News for MAIA
MAIA Secures FDA Fast Track for Lung Cancer Treatment
MAIA Biotechnology Receives FDA's Fast Track Designation for Ateganosine as a Treatment for ...
MAIA Biotechnology granted fast track designation for ateganosine
MAIA Biotechnology Publishes Groundbreaking Preclinical Data | MAIA Stock News
MAIA Biotechnology Announces Peer-Reviewed Journal Publication of Data Validating Second ...